[1]
M. Kałwik, “Anti-CD20 MONOCLONAL ANTIBODIES IN THE TREATMENT OF MULTIPLE SCLEROSIS: MECHANISMS OF ACTION, CLINICAL EFFICACY, SAFETY, AND CONTEMPORARY THERAPEUTIC PERSPECTIVES”, IJITSS, vol. 4, no. 3(51), Sep. 2026, doi: 10.31435/ijitss.3(51).2026.6456.